NIA announces major $73 million Alzheimer's grant, Emory leads international drug discovery center
The National Institute on Aging (NIA) is awarding approximately $37 million over five years to a team of international researchers, led by Emory University, to help accelerate the development of promising new therapies that will effectively treat or prevent Alzheimer’s disease (AD). NIA is part of the National Institutes of Health.
The grant is part of a larger $73 million-dollar program by NIA to establish the Alzheimer’s Centers for the Discovery of New Medicines, two new research centers designed to diversify and reinvigorate the Alzheimer’s disease drug development pipeline.
Allan Levey, MD, PhD, director of the Goizueta Alzheimer’s Disease Research Center at Emory and Haian Fu, PhD, chair of the Department of Pharmacology and Chemical Biology at Emory and a multi-PI of the grant are mentioned in this story. Dr. Levey is a NS faculty member and Dr. Fu is a faculty member in the CB and MSP Program.